Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice

Nephrology Dialysis Transplantation

Volumn 18, Issue 10, 2003, Pages 1999-2004

  Hartner, Andrea ^a   Cordasic, Nada ^a   Klanke, Bernd ^a   Veelken, Roland ^a   Hilgers, Karl F ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Albuminuria; Blood pressure; Deoxycorticosterone acetate; Glomerulosclerosis; Hypertension; Mouse strains

Indexed keywords

ALBUMIN; DEOXYCORTICOSTERONE ACETATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRINKING; GENETIC SUSCEPTIBILITY; GLOMERULOSCLEROSIS; HYPERTENSION; KIDNEY FIBROSIS; KIDNEY INJURY; MOUSE; MOUSE STRAIN; NEPHRECTOMY; NEPHROSCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; STRAIN DIFFERENCE;

ANALYSIS OF VARIANCE; ANIMALS; BIOPSY, NEEDLE; DESOXYCORTICOSTERONE; DISEASE MODELS, ANIMAL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; ORGAN SIZE; PROBABILITY; PROTEINURIA; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; SPECIES SPECIFICITY;

EID: 0141730380     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg299     Document Type: Article

References (14)

1. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 1995; 377: 744-747
2. Ichiki T, Labosky PA, Shiota C et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377: 748-750
3. Peng H, Carretero OA, Alfie ME, Masura JA, Rhaleb NE. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene. Hypertension 2001; 37: 974-980
4. Rhaleb NE, Peng H, Alfie ME, Shesely EG, Carretero OA. Effect of ACE inhibitor on DOCA-salt- and aortic coarctation-induced hypertension in mice: do kinin B2 receptors play a role? Hypertension 1999; 33: 329-334
5. Hartner A, Cordasic N, Klanke B, Muller U, Sterzel RB, Hilgers KF. The α8 integrin chain affords mechanical stability to the glomerular capillary tuft in hypertensive glomerular disease. Am J Pathol 2002; 160: 861-867
6. Wang Q, Hummler E, Nussberger J et al. Blood pressure, cardiac and renal responses to salt and deoxycorticosterone acetate in mice: role of renin genes. J Am Soc Nephrol 2002; 13: 1509-1516
7. Field LJ, McGowan RA, Dickinson DP, Gross KW. Tissue and gene specificity of mouse renin expression. Hypertension 1984; 6: 597-603
8. Sharp MG, Fettes D, Brooker G et al. Targeted inactivation of the Ren-2 gene in mice. Hypertension 1996; 28: 1126-1131
9. Hansen PB, Huang Y, Yang T, Mizel D, Briggs J, Schnermann J. Plasma renin in mice with one or two renin genes. J Am Soc Nephrol 2002; 13: 335A
10. Nakao N, Hiraiwa N, Yoshiki A, Ike F, Kusakabe M. Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture. Am J Pathol 1998; 152: 1237-1245
11. Oliveiro MI, Best CF, Smithies O, Coffman TM. A severe kidney phenotype in AT1A receptor-deficient mice. J Am Soc Nephrol 1997; 8: 406A
12. Brown DM, Provoost AP, Daly MJ, Lander ES, Jacob HJ. Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nat Genet 1996; 12: 44-51
13. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448-1456
14. Wright FA, O'Connor DT, Roberts E et al. Genome scan for blood pressure loci in mice. Hypertension 1999; 34: 625-630